| Makale Türü |
|
||
| Dergi Adı | BIOMEDICINE & PHARMACOTHERAPY | ||
| Dergi ISSN | 0753-3322 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 07-2014 |
| Kabul Tarihi | 12-04-2026 | Yayınlanma Tarihi | – |
| Cilt / Sayı / Sayfa | 68 / 6 / 729–736 | DOI | 10.1016/j.biopha.2014.08.013 |
| Makale Linki | http://linkinghub.elsevier.com/retrieve/pii/S0753332214001073 | ||
| Özet |
| Conventional cancer chemotherapies cannot differentiate between healthy and cancer cells, and lead to severe side effects and systemic toxicity. Another major problem is the drug resistance development before or during the treatment. In the last decades, different kinds of controlled drug delivery systems have been developed to overcome these shortcomings. The studies aim targeted drug delivery to tumor site. Magnetic nanoparticles (MNP) are potentially important in cancer treatment since they can be targeted to tumor site by an externally applied magnetic field. In this study, MNPs were synthesized, covered with biocompatible polyethylene glycol (PEG) and conjugated with folic acid. Then, anti-cancer drug idarubicin was loaded onto the nanoparticles. Shape, size, crystal and chemical structures, and magnetic properties of synthesized nanoparticles were characterized. The characterization of synthesized … |
| Anahtar Kelimeler |
| Idarubicin | Folic acid | Polyethylene glycol (PEG) | Magnetic nanoparticle | Drug delivery | MCF-7 |
| Atıf Sayıları | |
| Google Scholar | 84 |
| Web of Science | 67 |
| Dergi Adı | BIOMEDICINE & PHARMACOTHERAPY |
| Yayıncı | Elsevier Masson s.r.l. |
| Açık Erişim | Evet |
| ISSN | 0753-3322 |
| E-ISSN | 1950-6007 |
| CiteScore | 12,8 |
| SJR | 1,775 |
| SNIP | 1,561 |